420 with CNW – Colorado Kickstarts Marijuana Home Deliveries

In May 2019, Colorado Governor Jared Polis passed a bill that allowed home delivery for medical and recreational marijuana. The move was lauded by reform advocates and industry representatives who said it was a major step in the right direction for the state’s marijuana industry. The legislation granted licensed medical cannabis shops permission to deliver marijuana to their patients from January 2020, while recreational deliveries to adults 21 and older will start in January 2021.

This month, the state issued the first marijuana delivery license to Boulder-based medical cannabis dispensary The Dandelion, which is owned and operated by retail chain Native Roots. Ironically, the timing was purely coincidental and had nothing to do with the Coronavirus pandemic that’s currently wreaking havoc across the world.

“The timing is a total coincidence, but it’s timely. Medical delivery is really another option for patients to utilize social distancing,” says Sharon Fender, Director of Public Affairs for Native Roots. The virus is transmitted through droplets when an infected person coughs or sneezes, and medical experts state that social distancing and self-isolation are the best way to prevent new infections.

Authorities have been implementing Coronavirus measures meant to curb its spread, and all businesses except the most essential have to be shut down. Numerous states have included cannabis retailers in this group, and most of them have been looking into home deliveries and curbside pickups to reduce contact between customers.

The Dandelion’s delivery service will be available to patients living in either Boulder or the nearby town of Superior. They also have to be registered with the dispensary, and Native Roots has stated that it is ‘looking into a compliant, remote solution for patient registration’ for patients looking to sign up.

There is a $100 minimum purchase, and in accordance with advice from medical experts, the dispensary is advising customers to pay with debit cards and avoid cash changing hands.

At the moment, the world is on high alert as the Coronavirus pandemic throws systems that were in place for decades into disarray. Many economies are already showing the strain as businesses have been forced to shut down and millions rendered unemployed. Three months after appearing in Wuhan, China, the virus has infected over 700,000 individuals and left at least 30,000 dead. Home deliveries will help businesses stay afloat and allow people to buy what they need without compromising their health.

“The state rightfully prioritized the medical patient community for cannabis delivery, many of whom suffer from serious illnesses, pain and mobility issues. With permission from both municipal and state legislators, we are excited to begin the first-ever legal cannabis delivery service in Colorado. We are hopeful other jurisdictions will follow their lead and opt into medical delivery as soon as possible,” says Fender.

Experts see this commencement as yet another way through which the cannabis industry is contributing to limiting social contact at this time when the Coronavirus pandemic is raging. Sector players like SinglePoint Inc. (OTCQB: SING) are believed to be urging their customers to take advantage of every opportunity to receive consumer products in their homes without having to move out and risk being exposed to COVID-19.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Enters Definitive Agreement to Acquire Tassili Life Sciences Corp.

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a health and wellness company specializing in the formulation of medicinal mushrooms health products and novel delivery platforms for the pharmaceutical and nutraceutical industries, today announced its entry into a definitive agreement to acquire Tassili Life Sciences Corp. Per the update, the move will expand the Company’s preclinical trial pipeline, as well as its aggregation of broad intellectual property (IP) related to the development of novel psychedelics therapeutics and their delivery systems, targeting multiple pathological psychological diseases. Tassili has partnered with a multidisciplinary team of scientists and physicians at the University of Miami to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries (“mTBI”) and/or post-traumatic stress disorder (“PTSD”). “Mild traumatic brain injury, especially concussion, is a significant cause of morbidity worldwide,” Dr. Michael Hoffer, professor of otolaryngology and neurological surgery at University of Miami’s Miller School of Medicine, stated in the news release. “What many do not realize is that TBI often occurs alongside PTSD. Up to 40% of people impacted by mTBI, a head injury causing a temporary change in mental status or consciousness, or TBI in general, also suffer from PTSD. This combination of mTBI and PTSD is even more common in U.S military members and presents a vast patient population to service and potentially heal with our novel therapeutics under development.”

To view the full press release, visit http://cnw.fm/b3JCA

About Champignon Brands Inc.

Champignon Brands Inc. (CSE: SHRM) is a research driven company specializing in the formulation of a suite of medicinal mushrooms health products, as well as novel ketamine, anesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes for indications such as depression and Post Traumatic Stress Disorder (“PTSD”), as well as substance and alcohol use disorders. Champignon continues to be inspired by sustainability, as its medicinal mushroom infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Announces Receipt of Health Canada License Amendment for Ancaster Processing Facility

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, today announced its receipt of Health Canada’s approval for the licensing of the final component of its Ancaster site, the processing facility. According to the update, the license amendment includes approval of a state-of-the-art production facility designed to support processing activity that includes dedicated spaces for packaging of flower, oils, pre-rolls, and several Cannabis 2.0 products. “Receiving this license amendment was a key element of our 2020 operating plan. We made significant investments in this state-of-the-art facility, and now that it is fully licensed, Ancaster can finalize the ramp up of its production capacity,” TGOD CEO Brian Athaide said in the news release. “The processing facility reduces our reliance on third parties for packaging, secured storage, and for our next wave of 2.0 product launches. Beyond the successful launch of our TGOD Infusers, we are planning to launch a series of differentiated consumer packaged goods, including organic teas and vapes in Q2, as well as edibles, beverages and topicals later this year.”

To view the full press release, visit http://cnw.fm/k88sC

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US‐OTC: TGODF) is a premium certified organic cannabis company focused on the health and wellness market. Its certified‐organic cannabis is grown in living soil, as nature intended. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities are being built to LEED certification standards and its products are sold in recyclable packaging. In Canada, TGOD plans to expand its product portfolio by launching a series of next‐generation cannabis products such as organic teas, infusers and vapes. Through its European subsidiary, HemPoland, the Company also distributes premium hemp CBD oil and CBD-infused topicals in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale.

TGOD’s Common Shares and warrants issued under the indentures dated November 1, 2017 and December 19, 2019 trade on the TSX under the symbol “TGOD”, “TGOD.WT” and “TGOD.WS”, respectively. For more information on The Green Organic Dutchman Holdings Ltd., please visit www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://cnw.fm/TGOD

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Research Shows Cannabis Could Be a Potent Antibacterial

As the novel Coronavirus tears through most continents on the planet, one thing that’s become increasingly clear is that we have dropped the ball on hygiene. The disease is transmitted through droplets expelled from an infected person due to coughing or sneezing, and just a few months since it first appeared in Asia, it has caused quite some damage. More than 400,000 have been infected, and governments are imploring residents to practice social distancing coupled with constant and thorough hand washing to curb its spread.

The World Health Organization (WHO) recently announced that antibiotic-resistant bacteria may claim over 50 million lives by 2050, and this brings into question the availability and viability of alternative antibacterial options like cannabis.

Although the plant is still illegal at the federal level, there have been several studies into its medical capabilities. It produces a group of unique chemicals called cannabinoids, and they hold most of its medical potential. The most prevalent ones are THC, the psychoactive chemical responsible for marijuana’s high and cannabidiol (CBD), which is probably the most medically potent cannabinoid we know of at the moment.

Previous studies have found cannabis to be especially good at clearing bacteria, with a January 2020 study published in the Cureus Journal finding that it cleaned plaque better than over the counter hygiene products.

“Cannabinoids have the potential to be used as an effective antibacterial agent against dental plaque-associated bacteria. Moreover, it provides a safer alternative to synthetic antibiotics to reduce the development of drug resistance,” the researchers wrote.

Another study by the University of Queensland’s Institute for Molecular Bioscience’s Center for Superbug Solutions in Australia into cannabis’ antiseptic properties found that it was not only a potent anti-inflammatory but also has potential as an antibiotic. Researchers concluded that “cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics and did not lose effectiveness after extended treatment.”

Brandon Novy, a microbiology researcher at Reed College in Portland also presented a similar CBD focused study that found cannabidiol has the potential to fight gram-negative infections. Given WHO’s prediction of antibiotic-resistant bacteria, he believes these findings warrant more attention.

“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans and potential for varied delivery routes, it is a promising new antibiotic worth further investigation. The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly effective,” says Dr. Mark Blaskovich, lead researcher of the University of Queensland’s study.

It is widely believed by analysts that industry players like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) aren’t surprised by the research indicating cannabis’ antimicrobial properties, and more is yet to be discovered about this versatile plant.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Oklahoma Medical Marijuana Businesses Start Feeling the Pinch of Coronavirus

Medical marijuana businesses in Oklahoma have been left in a lurch after finding out they don’t have access to disaster relief funds to help cushion them from the Coronavirus’ economic fallout. And as more regions go into lockdowns to curb the spread of the disease, they have started feeling the pinch of reduced demand and sales.

Dubbed COVID-19, the virus first appeared in Wuhan, China late last year. A few months later, more than 400,000 have been infected and at least 20,000 have been left dead in its wake. It is a pandemic like we’ve never seen before, and experts say up to 70% of the world’s population may end up infected by the virus.

To prevent its spread, countries all over the world have started going into lockdowns, shutting down all but the most essential businesses and instructing residents to stay indoors and leave for only the most pressing reasons. While this will ultimately curb the spread of the Coronavirus, it has had adverse effects on the economy.

To help keep businesses from going under, the government has prepared a disaster relief fund, and through the federal Small Business Administration (SBA), it will disperse these monies to eligible businesses. Sadly, marijuana businesses don’t fall within this category.

John Koumbis, for instance, runs JKJ Processing, a company dedicated to making medical marijuana edibles, and he feels like his business and his patients’ quality of life are hanging in the balance. “Senior citizens, military, people with PTSD, high anxiety, how are we going to take their medicine to them?”

This is especially worrying as Oklahoma doesn’t allow the delivery of marijuana within its borders. “I’ve made 11 calls to the OMMA and the legislature, and I’m not getting any response,” he says, adding that if the state goes into lockdown, his business and others like it aren’t going to get anything.

Daniel Carnes, owner of Mary Jane dispensary in Moore is also worried as he has received little guidance from the authorities. However, like all other businesses, they have to comply with the Coronavirus related measures set forth by the state, and this will undoubtedly have a negative effect.

“At this time, I have not received any type of a memo or notification, other than much like other businesses to follow the protocols set forth by the governor,” he says.

To the governor, he says, “You’re leaving 270,000, more than quarter-million people in your state unattended to, and without any type of answers and no idea of what the future may hold.”

Experts say that the message about the 270,000 patients whose wellbeing hangs in the balance in Oklahoma is exactly similar to what other cannabis industry players, such as Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), are all concerned about wherever they have clients.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) New Operating Structure to Boost Efficiencies, Promote Long-Term Growth

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) continues to grow its portfolio as it identifies new opportunities that align with its mission to cultivate the world’s best cannabis and be recognized as a leader in the global industry. An article discussing the company reads, “To support its plans for long-term growth and to drive efficiencies, Supreme Cannabis Company recently implemented a new operating structure. As part of this new structure, the company has expanded distribution of its 7ACRES brand through an enhanced retail-sales strategy and partnership with humble+fume Inc., one of North America’s leading distributors of cannabis accessories. Through this partnership, Supreme Cannabis plans to create the only sales force in Canada able to offer a complete solution of recreational cannabis brands and accessories to retailers. . . . ‘With the number of retail stores in Canada quickly growing and cannabis consumers making their purchase decisions in store, having representation at the individual store level provides an essential opportunity for our business to drive near-term revenue growth and support our transition to a cannabis CPG company,’ Colin Moore, recently appointed director and interim president and CEO of Supreme Cannabis, stated in a news release (http://cnw.fm/6RluT). ‘Our partnership with humble+fume allows us to realize industry-leading sales coverage and focus our sales and marketing efforts at the most impactful stage of the cannabis consumer’s journey. We enter the second half of 2020 focused on the opportunity to address the Canadian market with competitive consumer brands supported by an unmatched sales force.’”

To view the full article, visit http://cnw.fm/qc7nI

About Supreme Cannabis Company Inc.

Supreme Cannabis is a global, diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the company has emerged as one of the world’s fastest-growing, premium, plant-driven lifestyle companies. Supreme Cannabis’ portfolio of brands caters to diverse consumer experiences, with brands and products that address recreational, wellness, medicinal and new-consumer preferences. The company’s brand portfolio includes 7ACRES, Blissco, Truverra, Sugarleaf by 7AC and Khalifa Kush Enterprises Canada. Supreme Cannabis’ brands are backed by a focused suite of world-class operating assets that serve key functions in the value chain, including scaled cultivation, value-add processing, centralized manufacturing and product testing, and R&D. For more information, visit the company’s website at www.Supreme.ca.

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://cnw.fm/FIRE

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Federal Agency Says Cannabis Businesses Aren’t Eligible for COVID-19 Disaster Relief

Marijuana businesses have been left between a rock and a hard place after the federal Small Business Administration (SBA) stated on Monday that marijuana companies aren’t eligible for relief to help cushion them against the Coronavirus pandemic.

Since the novel Coronavirus first appeared in Wuhan, China late last year, there have been over 450,000 confirmed cases and 21,000 deaths worldwide. Experts say that if the virus keeps spreading unabated, up to 70% of the world’s population might be infected before it runs its course. Understandably, countries have started implementing lockdown procedures to curb the spread of the disease.

This includes shutting down all but the most essential businesses, self-isolating, and personal distancing whenever you have to go out. And while these measures are essential during the pandemic, they have wreaked and will continue to wreak havoc on the economy. To help alleviate this, businesses meeting certain conditions will have access to disaster relief to help cushion the blow.

The marijuana industry, however, isn’t so lucky. Although several states have allowed marijuana within their borders, it still remains illegal at the federal level, and this denies it access to aid opportunities by federal agencies like the SBA.

“With the exception of businesses that produce or sell hemp and hemp-derived products that were federally legalized under the 2018 Farm Bill, marijuana-related businesses are not eligible for SBA-funded services,” stated a post by the agency’s Northwest branch in response to a tweet from a cannabis business owner inquiring about cannabis’ eligibility.

The SBA encouraged him to explore relief options provided by local or state agencies, stating that “even though federal law prohibits the SBA from providing direct assistance, there are great resources for small businesses from state and local sources.”

Carol Chastang, SBA public affairs specialist last week told the Cannabis Business Times that “because federal law prohibits the sale and distribution of cannabis, the SBA does not provide financial assistance to businesses that are illegal under federal law.” She goes on to say that businesses that aren’t eligible include marijuana growers and dispensaries and businesses that sell cannabis products, even if they are legal under state law.

This comes after a coalition of marijuana industry trade groups including the National Cannabis Industry Association National Cannabis Roundtable and the Cannabis Trade Federation signed a joint letter urging lawmakers to allow cannabis businesses access to disaster relief.

“The ineligibility of cannabis businesses for disaster relief assistance loans is especially inequitable given that these same businesses are required to comply with other Coronavirus related measures such as paid sick leave coverage,” state the letter in part.

“We are not seeking special treatment for state-legal cannabis businesses. We only seek to have them treated on an equal level as all other job-generating, tax-paying companies in this country.”

Experts believe that the news that cannabis businesses aren’t eligible for disaster relief will leave industry players like The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) wondering when the cannabis industry in the U.S. will ever get the equal treatment that it rightfully deserves.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Federal Agency Seeks Help in Standardizing THC Dosage

Cannabis has come a long way on its journey to legalization. Just a few years ago, it was illegal at both federal and state level, but now there are numerous states that allow medical or recreational marijuana within their borders. The plant is said to have potent medical properties that make it effective against a wide variety of ailments, but a lot of the evidence is anecdotal.

However, unlike ordinary pharmaceutical drugs, cannabis poses a challenge to researchers looking to provide standardized evidence of its efficacy and side effects. Its medicinal properties can be attributed to a group of unique chemicals called cannabinoids. Present only in the cannabis plant, they interact with the body and produce therapeutic effects. THC, the main psychoactive chemical, is produced in greater quantities than all other cannabinoids.

However, different cannabis varieties produce different levels of the chemicals, and this has made creating standard dosage a nightmare. To alleviate this and push forward research into the plant’s abilities, the National Institute on Drug Abuse (NIDA) is requesting advice from “the scientific community and other interested parties” to help establish a standard. This will ensure consistency among studies into the potential therapeutic benefits and risks of cannabis.

“One hindrance to conducting such research is the lack of a standardized measure of the THC in various cannabis products, making it hard to compare the results of different studies,” stated the agency in its request for information.

Published on Monday, the notice by NIDA admits that the agency knows little about the impact of varying THC potency and that creating a standard unit could help resolve the issue.

“As the diversity of products, potency, and use of cannabis increases, research grows ever more critical to determine both the adverse health effects and therapeutic potential of cannabis and its constituents. Recognizing that a perfect measure may not be attainable at the current time, NIDA still believes that a standard dose would improve measures of outcomes in relation to exposure, and this could inform policy and public health strategies around cannabis use.”

The notice also acknowledges that cannabis contains other chemicals (cannabinoids) that could complicate standardization, as well as the impact of different consumption methods. However, the agency states that “such a unit is critical for conducting rigorous cannabis research,” and it is looking into a five milligram THC dose as the standardized unit.

This comes a month after NIDA Director Nora Volkow discussed the importance of establishing a standardized THC unit. She stated that due to the lack of standardization, studies often show conflicting results. Ultimately, she says, the use of a standard unit dose of THC is an important step for improving our ability to understand the effects of cannabis in the population.”

Analysts are of the view that this request for advice will be seen as good news by sector players like Sugarmade Inc. (OTCQB: SGMD) who want to see some degree of agreement between the scientific community interested in investigating the properties of marijuana.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Plus Products Inc.’s (CSE: PLUS) (OTCQX: PLPRF) Distinguished Leadership Team Positions Company for Success

California-based cannabis-products company Plus Products (CSE: PLUS) (OTCQX: PLPRF) is led by a seasoned leadership team that boasts experience in technology, finance and social media. An article discussing the company reads, “The PLUS leadership team spans a wide range of expertise, work experience and industry exposure. After working at Facebook, CEO Jake Heimark co-founded PLUS. Chief strategy officer Craig Heimark lends high-powered finance expertise to the company gained from his experience at UBS and other similar firms. Managing the company’s finances is CFO Jon Paul, who brings more than 25 years of CFO experience to the team. . . . Navigating the constantly changing legal framework is chief risk officer Jennifer Tung, utilizing skills and expertise gained from her time spent at Uber and Facebook. Chief Scientific Officer Ari Mackler brings product knowledge to the company from his role as VP of clinical development at the Wonderful Company, as well as his PhD in neuroendocrinology.”

To view the full article, visit http://cnw.fm/iqu7C

About Plus Products Inc.

PLUS is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable — beginning with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, California. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLUS

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Establishing Foothold in China’s Rising CBD Market

ChineseInvestors.com (OTCQB: CIIX) is leveraging its financial expertise to establish itself as a leader in China’s emerging cannabidiol (“CBD”) market. CIIX CEO Warren Wang recently discussed the potential health benefits offered by the company’s CBD-based products in an interview with MoneyTV’s Donald Baillargeon (http://cnw.fm/V4vSv). An article discussing the company reads, “Speaking about CIIX’s current efforts to promote the power of CBD oil, Wang announced that the company entered a deal with Vitamist, an organization that produces premium-quality supplements for health-conscious consumers. ‘Our company is very helpful for Chinese people,’ added Wang. ‘I see tremendous opportunities here within the next three to six months to spread our word, create a community and then sell our products on CBDoil.com.’ . . . With a decades-long successful track record, a robustly diversified business model and increased demand globally for its health and wellness products, CIIX is a compelling investment opportunity for investors seeking to harness the benefits of high-potential companies.”

To view the full article, visit http://cnw.fm/5ejXU

About ChineseInvestors.com Inc.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.